256 related articles for article (PubMed ID: 22485142)
1. Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.
Lim EJ; Hong DY; Park JH; Joung YH; Darvin P; Kim SY; Na YM; Hwang TS; Ye SK; Moon ES; Cho BW; Do Park K; Lee HK; Park T; Yang YM
PLoS One; 2012; 7(4):e33361. PubMed ID: 22485142
[TBL] [Abstract][Full Text] [Related]
2. Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway.
Joung YH; Na YM; Yoo YB; Darvin P; Sp N; Kang DY; Kim SY; Kim HS; Choi YH; Lee HK; Park KD; Cho BW; Kim HS; Park JH; Yang YM
Int J Oncol; 2014 Mar; 44(3):883-95. PubMed ID: 24402583
[TBL] [Abstract][Full Text] [Related]
3. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.
Park JH; Darvin P; Lim EJ; Joung YH; Hong DY; Park EU; Park SH; Choi SK; Moon ES; Cho BW; Park KD; Lee HK; Kim MJ; Park DS; Chung IM; Yang YM
PLoS One; 2012; 7(7):e40531. PubMed ID: 22792362
[TBL] [Abstract][Full Text] [Related]
4. Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells.
Kang DY; Darvin P; Yoo YB; Joung YH; Sp N; Byun HJ; Yang YM
Int J Oncol; 2016 Feb; 48(2):836-42. PubMed ID: 26648017
[TBL] [Abstract][Full Text] [Related]
5. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs.
Joung YH; Lim EJ; Darvin P; Chung SC; Jang JW; Do Park K; Lee HK; Kim HS; Park T; Yang YM
PLoS One; 2012; 7(10):e47477. PubMed ID: 23071812
[TBL] [Abstract][Full Text] [Related]
6. The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.
S P N; Darvin P; Yoo YB; Joung YH; Kang DY; Kim DN; Hwang TS; Kim SY; Kim WS; Lee HK; Cho BW; Kim HS; Park KD; Park JH; Chang SH; Yang YM
BMC Cancer; 2015 Jun; 15():474. PubMed ID: 26084564
[TBL] [Abstract][Full Text] [Related]
7. Hemin inhibits cyclin D1 and IGF-1 expression via STAT5b under hypoxia in ERalpha-negative MDA-MB 231 breast cancer cells.
Lim EJ; Joung YH; Jung SM; Park SH; Park JH; Kim SY; Hwang TS; Hong DY; Chung SC; Ye SK; Moon ES; Park EU; Park T; Chung IM; Yang YM
Int J Oncol; 2010 May; 36(5):1243-51. PubMed ID: 20372799
[TBL] [Abstract][Full Text] [Related]
8. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
9. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
10. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
[TBL] [Abstract][Full Text] [Related]
11. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
12. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
13. Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.
Terwisscha van Scheltinga AG; Berghuis P; Nienhuis HH; Timmer-Bosscha H; Pot L; Gaykema SB; Lub-de Hooge MN; Kosterink JG; de Vries EG; Schröder CP
Eur J Cancer; 2014 Sep; 50(14):2508-16. PubMed ID: 25027745
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.
Varco-Merth B; Rotwein P
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E847-55. PubMed ID: 25205818
[TBL] [Abstract][Full Text] [Related]
15. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
[TBL] [Abstract][Full Text] [Related]
17. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Gupta P; Srivastava SK
BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
[TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
20. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
